Welcome : Guest

Press Release


MCP-3417: PEPTIC ULCER TESTING – A GLOBAL STRATEGIC BUSINESS REPORT

January 10, 2017 – Need for Faster & Accurate Diagnosis of H. Pylori Infection Drives Growth in the Global Peptic Ulcer Testing Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Peptic Ulcer Testing market. The global market for Peptic Ulcer Testing is projected to reach US$525 million by 2022, driven by the higher prevalence rates in third world countries and the growing need for faster and accurate diagnosis of H. Pylori infection.

Peptic ulcer disease is among the most common diseases affecting people of all age groups and gender, globally. Also termed as stomach ulcer, peptic ulcer disease causes a break in the stomach’s lining, generally in the first part of small intestine and sometimes in the lower esophagus. At present, about 4-5% of the global population is known to suffer from peptic ulcers. Also about a tenth of the world population is known to be affected by peptic ulcers at some point through their entire life. Peptic ulcer disease is caused by Helicobacter pylori infection or due to the use of non-steroidal anti-inflammatory drugs (NSAIDs). Of the various causal factors, H. pylori bacterium is identified as the major cause of most peptic ulcer disease cases with nearly 90% of all peptic ulcers attributed to H. pylori infection. While the number of H. pylori infected population is huge, actual number of people becoming symptomatic is negligible, which enhances the significance of accurate diagnosis of H. pylori. The choice of diagnostic method for detecting H. pylori infection depends on factors such as the cost, accessibility, patient’s age, availability of diagnostic tests, advantages and drawbacks of various tests, and need for performing endoscopy.

Testing market for peptic ulcer disease is witnessing a steady shift towards more advanced methods that can deliver accurate and rapid results and can be performed by technically less-qualified healthcare professionals compared to conventional testing procedures that necessitate presence of highly trained personnel and involves longer duration for delivering results. Development of new testing techniques, increased importance on healthcare, and the growing pressure on governments across the world to contain ever-increasing healthcare costs are also fuelling growth in the market for rapid microbiological tests. Since rapid diagnostic testing methods are capable of delivering accurate diagnoses in a timely manner, physicians can speed up treatment thus reducing hospital stays, enabling early recovery, and lowering treatment costs. The market is especially experiencing increased demand for point-of-care devices that physicians can use at their office, as these are cost-effective and save time compared to tests performed at reference laboratories.

As stated by the new market research report on Peptic Ulcer Testing, Asia-Pacific represents the largest market worldwide supported by the high incidence of H. pylori infection in developing nations as a result of poor sanitary conditions and unsafe drinking water which expose a significant proportion of the population to the infection. Other factors driving growth in the region include growing healthcare spending as a result of rising disposable income, improving access to affordable healthcare as a result of government efforts to provide equitable healthcare services, and growing awareness over the importance of timely diagnosing and treating stomach ulcers. The prevalence of H. pylori infection remains low and continues to decline at a steady rate in most developed countries.

Major players covered in the report include Becton Dickinson and Company, Beckman Coulter Inc., Biomerica Inc., Biohit Oyj, bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., EKF Diagnostics, Exalenz Bioscience Ltd., Halyard Health Inc. , Kibion AB, Meridian Bioscience Inc., Otsuka America Pharmaceutical Inc., Orion Diagnostica Oy, Polymedco CDP LLC, Quidel Corporation, Sekisui Diagnostics LLC, and Thermo Fisher Scientific Inc., among others.

The research report titled “Peptic Ulcer Testing: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets such as the US, Japan, Europe, Asia-Pacific, Latin America and Rest of World.

 

» View Complete Report Details

« Back